Sklerodermie

  • H. W. Baenkler

Zusammenfassung

Bei der Sklerodermie handelt es sich um einen Prozeß des Bindegewebes, der in unterschiedlichem Ausmaß in Form einer Fibrose oder quasi degenerativer Veränderungen Parenchym und Gefäßapparat zahlreicher innerer Organe wie Lungen, Herz, Nieren, Magendarmkanal und Bewegungsapparat erfaßt. Die Zahl der Varianten ist groß; sie lassen sich teilweise auch als Übergangsformen zu anderen Immunopathien begreifen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Alarcôn-Segovia D (1976) Immunological aspects of scleroderma. In: Hughes GRV (ed) Modern topics in Rheumatology. Heinemann, LondonGoogle Scholar
  2. Cunningham P-H, Andrews BS, Davis JS (1980) Immune complexes in progressive systemic sclerosis and MCTD. Journal of Rheumatology 7: 301–308PubMedGoogle Scholar
  3. Emerit I (1976) Chromosomal breakage in systemic sclerosis and related disorders. Dermatologia 153: 145–146CrossRefGoogle Scholar
  4. Keystone EC, Gladman DD, Baron M, Cane D, Paplonski L (1981) Antigen- specific suppressor cell activity in patients with scleroderma. Journal of Rheumatology 8: 747–751PubMedGoogle Scholar
  5. Krawitt E, Holdstock G, Bland J, Chastenay B, Albertini R(1982) Suppressor cell activity in progressive systemic sclerosis. Journal of Rheumatology 9: 263–267Google Scholar
  6. Kühn K, Krieg T (1986) Connective Tissue: Biological and Clinical Aspects. Karger, BaselGoogle Scholar
  7. LeRoy EC (1981) Scleroderma (Systemic sclerosis) In: Kelley WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of Rheumatology. Saunders, PhiladelphiaGoogle Scholar
  8. Perlish JS, Basterey RJ, Stephens RE, Fleischmajer R (1976) Connective tissue synthesis by cultured scleroderma fibroblasts. Arthritis and Rheumatism 19: 891–901PubMedCrossRefGoogle Scholar
  9. Resnick D (1981) Scleroderma (Progressive systemic sclerosis) In: Resnick D, Niwayama G (eds) Diagnosis of Bone and Joint Disorders. Saunders, PhiladelphiaGoogle Scholar
  10. Rodnan G (1980) Progressive Systemic Sclerosis (Scleroderma) In: Parker CW (ed) Clinical Immunology I. Saunders, PhiladelphiaGoogle Scholar
  11. Seelig HP (1984) Antikörper gegen Zellkernantikörper. Gustav Fischer, Stutt¬gartGoogle Scholar
  12. Talpos G, White JM, Horrocks M, Cotton LT (1978) Plasmapheresis in Raynaud’s disease. Lancet I: 416–417Google Scholar
  13. Wick G, Kraft D, Kokoschka EM, Timpl R (1976) The diagnostic application of specific anti-procollagen sera. I. Analysis of skin biopsies. Clinical Immunology and Immunopathology 6: 182–191Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • H. W. Baenkler

There are no affiliations available

Personalised recommendations